2021 annual financial data
Aldeyra Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -56,219,536 USD and net income was -57,776,274 USD.
Operating cash flow was -42,555,907 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -56,219,536 USD
- Net income
- -57,776,274 USD
- Operating cash flow
- -42,555,907 USD